October 30, 2007 - Bracco Diagnostics, the subsidiary of contrast media developer Bracco Imaging, will acquire E-Z-EM at $21 a share for an estimated total of $241 million.

Independent members of E-Z-EM's board of directors have approved the agreement as well as a group of E-Z-EM stockholders, who represent approximately 34 percent of E-Z-EM’s outstanding shares.

October 30, 2007) – TherOx Inc., a privately held medical device company, announced it has met its endpoints for its pivotal trial, AMIHOT II (Acute Myocardial Infarction with Hyperoxemic Oxygen Therapy), which studied SuperOxygenation Therapy for Acute Myocardial Infarction (AMI) patients.

October 30, 2007— Philips today announced the North American release of Philips Xcelera, a multi-modality image management, physician reporting and information distribution system, designed to help solve organization and workflow challenges.

October 30, 3007 - ATS Medical Inc., manufacturer and marketer of state-of-the-art cardiac surgery products and services, announced the FDA gave it clearance for the ATS Simulus Semi-Rigid Annuloplasty Ring designed for mitral valve repair.

October 30, 2007 - Cordis Corp. will launch in the U.S. and European its next generation carotid stent system, the PRECISEPRO RX Nitinol Self-Expanding Stent, to treat clogged neck arteries, in order to offer physicians a broader range of treatment options for patients with carotid artery disease.

October 30. 2007 - Ovalum Ltd., a privately held Israeli medical device company, has received FDA marketing clearance for the CiTop Guidewire system for angiographic procedures in the peripheral vasculature, a device intended to assist in the treatment of chronic complete arterial blockage (CTO).

October 30, 2007 – The National Institutes of Health (NIH) has awarded cardiac researchers at the University of Pennsylvania a $2.1 million grant to pioneer studies in cardiovascular disease management and participate in a novel collaboration network to develop and implement research in this critically important field.

October 30, 2007- SonoSite Inc. today introduced the S-Cath visualization tool, a specialized ultrasound device designed to meet the specific point-of-care imaging and procedural guidance needs of interventional radiologists and cardiologists.

October 23, 2007 – Boston Scientific Corp. announced five-year and final follow-up data from its TAXUS IV clinical trial demonstrated long-term safety, with no new cases of stent thrombosis between years four and five.

October 29, 2007 - Boston Scientific Corp. announced positive three-year results from its CABERNET and BEACH carotid artery stenting clinical trials, which evaluated the effectiveness of stenting with embolic protection for patients at high risk for carotid endarterectomy (CEA), the surgical treatment for carotid artery disease.

Subscribe Now